Want to join the conversation?
Saint Paul, Minnesota-based company $STJ said that for 1Q16, total heart failure sales were $374MM, up 2% YoverY. The company continues to expect FY16 CardioMEMS sales to be approx. $65MM. Atrial Fibrillation product sales totaled $291MM, up 9% and Neuromodulation total sales were $116MM, up approx. 10%. Conversely, Traditional CRM sales fell 7%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?